Publications by authors named "Amoge Chidinma Ogu"
Article Synopsis
- Lassa fever is caused by the Lassa virus and there is no existing licensed vaccine; the study focuses on creating a multi-epitope vaccine candidate from the virus's envelope glycoprotein.
- The researchers analyzed 26 strains of LASV for key immune responses and designed a vaccine candidate that incorporates immunodominant epitopes, which was then tested for its properties and stability.
- The resulting vaccine candidate appears to be promising for preventing Lassa fever, but additional testing is necessary to confirm its safety and effectiveness.
The COVID-19 pandemic constitutes an arduous global health challenge, and the increasing number of fatalities calls for the speedy pursuit of a remedy. This review emphasizes the changing aspects of the COVID-19 disease, featuring the cytokine storm's pathological processes. Furthermore, we briefly reviewed potential therapeutic agents that may modulate and alleviate cytokine storms.
View Article and Find Full Text PDF